Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Authors: M Ahmed, F Lalloo, A Howell, DG Evans

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

Mutations in BRCA1 and BRCA2 confer high lifetime risks of breast cancer. Previous studies have suggested, following an initial diagnosis, the risk for a contralateral breast cancer is approximately 3% annually or up to 40% at 10 years. The results presented here are of contralateral breast cancer risk in BRCA1/BRCA2 mutation carriers. …
Metadata
Title
Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Authors
M Ahmed
F Lalloo
A Howell
DG Evans
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2511

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Lecture presentation

Recent advances in treatment of metastatic breast cancer

Poster presentation

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest

Poster presentation

Radiotherapy fraction size sensitivity is modulated by DNA repair systems

Poster presentation

Assessing the functional role of caspase-8 gene variants in breast cancer

Lecture presentation

Biomarkers for the diagnosis and prediction of therapeutic response in clinical breast cancer

Poster presentation

Identification of molecular subtypes within a formalin-fixed, paraffin-embedded breast cancer tumour cohort
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits